STAA Q1 2020 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q1 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$35M+8.0% YoY

Gross Profit

$25M70.4% margin

Operating Income

-$1M-3.2% margin

Net Income

-$134,000-0.4% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-9.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$207M

Total Liabilities

$42M

Stockholders' Equity

$165M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$33M	+8.0%
Gross Profit	$25M	$24M	+2.4%
Operating Income	-$1M	$2M	-172.5%
Net Income	-$134,000	$1M	-109.8%

Revenue Segments

Implantable Collamer Lenses

$29M83%

Intraocular Lenses

$4M11%

Other Surgical Products

$2M5%